As previously reported yesterday afternoon, Canaccord upgraded Vertex Pharmaceuticals (VRTX) to Hold from Sell with a price target of $424, up ...

Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs, and this platform has helped it generate billions of dollars in ...

DeepSeek is the little-known (until this week) Chinese artificial intelligence start-up that has its American rivals, and US investors, on edge. Marc Andreessen, the veteran venture capitalist ...

Integrate the Microsoft Graph API into your .NET project! The Microsoft Graph .NET Core Client Library contains core classes and interfaces used by Microsoft.Graph Client Library to send native HTTP ...

Vertex has built an empire in cystic fibrosis (CF) treatment, recently crowning its dominance with Alyftrek's approval last month. This latest CF drug adds even more firepower to a franchise ...

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...